Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial

Biteker M., Duran N. E., Kaya H., Gunduz S., Tanboga H. I., Gokdeniz T., ...Daha Fazla

CLINICAL RESEARCH IN CARDIOLOGY, cilt.100, sa.7, ss.571-577, 2011 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 100 Sayı: 7
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1007/s00392-010-0279-7
  • Dergi Adı: CLINICAL RESEARCH IN CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.571-577
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Levosimendan is a promising new inodilator agent but its effectiveness in peripartum cardiomyopathy (PPCM) has not been tested in a clinical trial. The authors sought to evaluate the effect of levosimendan therapy and to determine the predictors of clinical outcome in patients with PPCM.